Skip to main content
. 2013 Sep 17;170(3):459–474. doi: 10.1111/bph.12274

Table 1.

Inhibition by pyrazole-based compounds 12–17 (Kiyonaka et al., 2009)

Figure 3 compounds IC50 (μM)
TRPC1 TRPC3 TRPC4 TRPC5 TRPC6 TRPC7
12 (Pyr2) n.d. 4.2 n.d. 0.1–1 1–10 1–10
13 (Pyr3) n.d. 0.5 n.d. >10 >10 >10
14 (Pyr4) n.d. 0.3–3 n.d. >10 1–10 1–10
15 (Pyr5) n.d. 0.1–1 n.d. >10 >10 >10
16 (Pyr6) n.d. 18.5 >10 >10 >10 n.d.
17 (Pyr10) n.d. 0.7 >10 >10 >10 n.d.

n.d., not determined; TRPC, Transient Receptor Potential Canonical.